Diabetes Drugs Investigated

• Autores: Bridget M. Kuehn
• Localización: JAMA: the journal of the American Medical Association, ISSN 0098-7484, Vol. 309, Nº. 16, 2013, pág. 1674
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The US Food and Drug Administration (FDA) is investigating unpublished data suggesting that incretin mimetics used to treat type 2 diabetes may increase the risk of pancreatitis or precancerous changes in the pancreas